Clinical Trials

Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Other, Diagnostic Test, Drug
  • Participants: 100000
  • Start Date: April 5, 2021
The Registry of Oncology Outcomes Associated With Testing and Treatment (ROOT)
Search for trials
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Biological, Procedure, Radiation, Drug
  • Participants: 25
  • Start Date: October 14, 2020
A Phase I Study of Nivolumab and Intratumoral BO 112 for Resectable Soft Tissue Sarcoma
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Biological
  • Participants: 68
  • Start Date: July 13, 2020
Phase I Study of B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1/Phase 2
  • Intervention Type: Drug
  • Participants: 33
  • Start Date: March 4, 2020
A Randomized, Open-Label Phase 1/2 Study Evaluating Ramucirumab in Pediatric Patients and Young Adults With Relapsed, Recurrent, or Refractory Synovial Sarcoma
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Drug
  • Participants: 200
  • Start Date: January 6, 2020
Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Drug, Other
  • Participants: 28
  • Start Date: September 30, 2019
A Pilot Study Examining the Impact of the Jak1 Inhibitor Itacitinib on the Sarcoma Tumor Immune Microenvironment
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Genetic
  • Participants: 90
  • Start Date: July 24, 2019
A Phase 2 Single Arm Open-Label Clinical Trial of ADP-A2M4 SPEAR™ T Cells in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
Showing 1-12 of 39